Pillsbury Advises Thyme Care in $95M Capital Raise
July 25, 2024
July 25, 2024
NEW YORK, July 25 -- Pillsbury, a law firm, issued the following news release:
Pillsbury advised Thyme Care, the leading value-based cancer care enabler, in its recent $95 million capital raise.
New investor Concord Health Partners joined existing investors CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital in funding the $55 million Series C equity financing and Banc of California wi . . .
Pillsbury advised Thyme Care, the leading value-based cancer care enabler, in its recent $95 million capital raise.
New investor Concord Health Partners joined existing investors CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital in funding the $55 million Series C equity financing and Banc of California wi . . .